Low-dose IL-2 administration was found to attenuate inflammatory responses and anxiety-like behaviors [17,18,19] in patients with autoimmune diseases, as well as attenuate depression-like behaviors in a depression model of olfactory bulbectomized rats [20]. This evidence concerns the gene IL2 and major depressive disorder.